Date | Title | Description |
17.09.2024 | Respiree teams up with Roche Diagnostics in APAC to introduce a new simplified way of hospital patient monitoring | With this collaboration, Respiree's patient monitoring solution will be made available for healthcare professionals in APAC through a pilot program using Roche's blood glucose monitoring system. The goal is to simplify clinical workflows an... |
14.09.2024 | The Intersection of Health and Innovation: A Weekly Snapshot | In the fast-paced world of healthcare, news can feel like a tidal wave. Each week, a multitude of press releases flood the media landscape, highlighting breakthroughs, initiatives, and pressing issues. This week is no different. From advanc... |
13.09.2024 | The New Wave of Healthcare Innovation: Leaders Shaping the Future | The healthcare landscape is evolving. Two recent appointments highlight this shift. Closed Loop Medicine and Highlander Health are at the forefront, steering the ship toward a more personalized and efficient future. Closed Loop Medicine, a ... |
13.09.2024 | Weekly Recap: 12 Health Press Releases You Might Have Missed | A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Children's Growth Awareness Week, the effects of climate change on health and new innovations in AI health diagnostics.
NEW YORK, Sept. 13, 202... |
13.09.2024 | FDA approves Roche’s Tecentriq Hybreza, the first and only subcutaneous anti-PD-(L)1 cancer immunotherapy | Tecentriq Hybreza provides patients and physicians with greater flexibility of treatment options while showing safety and efficacy consistent with intravenous
(IV) Tecentriq1,2New subcutaneous (SC) option reduces treatment time to approxima... |
12.09.2024 | Qritive Joins Forces with Roche to Redefine Global Cancer Diagnostics with AI | SINGAPORE, Sept. 12, 2024 /PRNewswire/ -- Qritive, a leading digital pathology and AI company headquartered in Singapore, is proud to announce its collaboration with Roche, one of the largest diagnostics and life sciences companies in the w... |
11.09.2024 | Closed Loop Medicine appoints Luba Greenwood as Chair of the Board of Directors | Appointment of notable investor and executive in healthcare and tech to support leadership team in preparation for commercial milestones
London, UK, 11 Sep 2024: Closed Loop Medicine Ltd., a leading TechBio company leveraging AI, machine le... |
10.09.2024 | Дешевле, эффективнее и без уколов. Новый «Оземпик» на подходе | Кажется, что человечество стало еще на шаг ближе к исполнению «ленивых желаний». Никаких тренировок, никакой диеты – закинул таблетку и почти безвредно похудел. И если препарат Оземпик стоил дорого и вводился иглой, то теперь на рынке новый... |
09.09.2024 | Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing | Lunit's AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche's navify® Digital Pathology platform to enhance precision medicine and improve cancer biomarker testing
SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Lunit (KRX:... |
06.09.2024 | Inventive AI: RFP Optimization Platform Raises $4 Million (Seed) | Inventive AI, an AI-based tool for streamlining and optimizing RFP (Request for Proposal) and sales questionnaire workflows, announced the successful closure of its seed funding round, raising $4 million. Sierra Ventures led this funding ro... |
05.09.2024 | The Intersection of AI and Culinary Art: A Tale of Two Innovations | In the world of technology and food, two distinct realms are emerging with fervor. One is the realm of artificial intelligence, where data dances and algorithms weave magic. The other is the culinary landscape, where flavors blend and tradi... |
04.09.2024 | Success! Cancer Survivor Julia Brookshire and Olympic Swimmer Janel Jorgensen McArdle Successfully Swim "World's Oldest" Hellespont and Dardanelles Open Water Swim | Julia Brookshire and Janel Jorgensen McArdle at the historic Hellespont and Dardanelles swim on August 30th, celebrating Brookshire’s CLL remission and raising funds for Swim Across America.
Swimmer Friends and Colleagues Completed Swim Aug... |
04.09.2024 | John Snow Labs Announces Fifth Annual NLP Summit | John Snow Labs, the AI for healthcare company, announced the program for the fifth annual NLP Summit, taking place virtually September 24-26. The free conference, which attracted over 10,000 attendees last year, is the world’s largest gathe... |
04.09.2024 | Roche’s fenebrutinib demonstrated near-complete suppression of disease activity and disability progression for up to 48 weeks in patients with relapsing multiple sclerosis | New Phase II data show vast majority of patients experiencing no relapses or disability progressionFenebrutinib suppressed acute and chronic MRI lesionsFenebrutinib’s safety profile was consistent with previous and ongoing clinical trials a... |
03.09.2024 | EPFL startup offering Consulting services gets acquired |
Effixis, founded in 2017 by EPFL alumni, is a consultancy company specializing in artificial intelligence and business solutions. With currently 24 employees, the company offers a comprehensive range of services, including AI education thr... |
03.09.2024 | Parkinson’s Disease Drug Market: Trends, Growth, and Segmentation | Share
Tweet
Share
Share
Email
Parkinson’s disease, a progressive neurodegenerative disorder characterized by motor symptoms such as tremors, rigidity, and bradykinesia, affects millions of individuals worldwide. As the global population age... |
03.09.2024 | General Anesthesia Drugs Market: Trends, Segmentation, and Future Outlook | Share
Tweet
Share
Share
Email
The global general anesthesia drugs market has been experiencing significant evolution, driven by advancements in medical technology, increasing surgical procedures, and a growing emphasis on patient safety and... |
03.09.2024 | Next Generation Sequencing Market is poised to grow from USD 36.04 billion by 2031: Skyquest Technology | Share
Tweet
Share
Share
Email
In recent years, next generation sequencing is a technique that employs massive parallelism in sequencing millions or even billions of DNA strands. This method is also known as high throughput sequencing. NGS i... |
03.09.2024 | Pharmaceutical Market: Trends, Segmentation, and Growth Opportunities | Share
Tweet
Share
Share
Email
In recent years, the pharmaceutical market has witnessed remarkable growth and transformation, driven by technological advancements, evolving consumer needs, and the global push for better healthcare solutions.... |
02.09.2024 | Innovent Annouces Multiple Clinical Study Results of Mazdutide to be Presented at the EASD 2024 | SAN FRANCISCO and SUZHOU, China, Sept. 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for ... |
30.08.2024 | Sergey Baranovskiy Leading a New Wave of Global Pharmaceutical Innovation | Share
Tweet
Share
Share
Email
Presently stationed in the UAE and plotting a strategic foray into the United States, Sergey Baranovskiy is a man who has spent more than a decade orchestrating the direction of pharmaceutical research and deve... |
29.08.2024 | Innovent and Lilly: Pioneering Paths in Biopharmaceuticals | In the ever-evolving landscape of biopharmaceuticals, two companies stand out: Innovent Biologics and Eli Lilly. Both are making waves, each with a unique approach to tackling pressing health issues. Innovent, based in Suzhou, China, is car... |
29.08.2024 | Scots Tech Services Firm Waracle Announces New CEO | Waracle, the Dundee-headquartered tech and digital developer, will welcome David Tuck, former group chief executive of digital transformation consultancy Kin + Carta, to the business in early September.
He succeeds chief executive Chris Mar... |
29.08.2024 | Innovent to Present Clinical Data of Multiple Novel Molecules at WCLC and ESMO 2024 | SAN FRANCISCO and SUZHOU, China, Aug. 29, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for ... |
28.08.2024 | Innovent Announces 2024 Interim Results and Business Updates | Strong commercial performance and significant pipeline milestones
support sustained growth and innovation
SAN FRANSISCO and SUZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopha... |
27.08.2024 | Roche’s PiaSky approved in the EU as the first monthly subcutaneous treatment for people with PNH | With the option to self-administer, PiaSky® (crovalimab) has the potential to reduce treatment burden for people with paroxysmal nocturnal haemoglobinuria (PNH) in Europe and their caregiversApproval is based on COMMODORE 2, where subcutane... |
27.08.2024 | ArkBio Presented at the 8th Annual IPF Summit and Announced Completion of Patient Enrollment for Phase 2 Clinical Trial of AK3280, a Next-Generation Drug for IPF Treatment | BEIJING, Aug. 27, 2024 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio"), a privately held, clinical-stage biopharmaceutical company today announced that Dr. Jim Wu, Chief Executive Officer of ArkBio, gave an ora... |
26.08.2024 | Opna Bio Doses First Patient in Phase 1 Study in Multiple Myeloma with OPN-6602, an EP300/CBP Bromodomain Inhibitor | Appoints Axel Bolte, MBA, MSc, to Board Director and Stephanie Oestreich, PhD, MPA, to Board Observer
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–August 26, 2024–
Opna Bio announced that it has dosed the first patient with OPN-6602, a poten... |
13.08.2024 | Myrobalan Therapeutics: Additional $9 Million Raised And Grant Bogle Joins Board | Myrobalan Therapeutics, a biotechnology company developing novel oral small-molecule therapies to repair damage and restore brain function in high-unmet need central nervous system (CNS) conditions, announced the appointment of Grant C. Bog... |
13.08.2024 | Takeda, Roche, and Genentech Recognized by the Healthcare Businesswomen's Association for Advancing Women in the Workplace Initiatives | UCB Transformational Program Also Honored
FAIRFIELD, N.J., Aug. 13, 2024 /PRNewswire/ -- To showcase the impactful commitment and outcomes of equitable practices for women in the workplace, the Healthcare Businesswomen's Association (HBA) t... |
12.08.2024 | Symbiotic Capital: Life Science Credit Firm Raises Over $600 Million | Global life science credit firm Symbiotic Capital has been officially unveiled with more than $600 million in capital committed and targeted for investments and co-investments. Symbiotic Capital is affiliated with Bellco Capital, a Los Ange... |
09.08.2024 | Roche намерен продать стартап по сбору данных о раке стоимостью $1,9 млрд | В 2018 году компания Roche заплатила $1,9 млрд нью-йоркской компании Flatiron Health, чтобы ускорить разработку ею противораковых препаратов и поддержать ее усилия по установлению цен на них в зависимости от эффективности их работы.
В сообщ... |
05.08.2024 | Drei Startups mit Mission Markteintritt in Deutschland |
Urban Connect ermöglicht es Unternehmen, nachhaltige Mitarbeitermobilität auf eine neue Art und Weise zu fördern. Seine B2B-Lösung bietet Unternehmen und deren Angestellten den Zugang zu einem vollständig integrierten Ökosystem von geteilt... |
05.08.2024 | Lupin completes Phase-III global trial on biosimilar of Lucentis | Drugmaker Lupin has completed advanced clinical trials (Phase III) of its biosimilar version of Roche’s Lucentis (ranibizumab), used to treat age-related macular degeneration (AMD).
About 600 patients from India, the US, the European Union ... |
03.08.2024 | Tech Giants Stumble as Pharma Industry Rises in Germany | July 2024 was a month of turbulence for the tech giants. The once soaring market caps of companies like Alphabet and Microsoft took a nosedive. Investors, once enamored with the promise of artificial intelligence, began to question the sust... |
02.08.2024 | OutSystems Unveils Speaker Line-Up at ONE Conference | Industry leaders from Axos Bank, Bosch, Carrefour, Gartner, Roche and more to participate in 2024 speaker program
SINGAPORE, Aug. 2, 2024 /PRNewswire/ -- OutSystems, a global leader transforming how companies innovate through software, toda... |
01.08.2024 | Curis Provides Second Quarter 2024 Financial and Operating Update | EC Grants ODD to emavusertib in PCNSL
Management to host conference call and webcast today at 8:30 a.m. ET
LEXINGTON, Mass., Aug. 1, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emav... |
01.08.2024 | Germany Attracts Another Billion-Euro Pharma Project | French pharmaceutical giant Sanofi has confirmed it will invest 1.3 billion euros to expand insulin production in the western German city of Frankfurt am Main.
BERLIN, Aug. 1, 2024 /PRNewswire/ -- Sanofi says the expansion will encompass ar... |
01.08.2024 | Tech giants faced major market cap drop in July on earnings worries | Previous
FILE PHOTO: Figurines with computers and smartphones are seen in front of Alphabet logo in this illustration taken, February 19, 2024. REUTERS/Dado Ruvic/Illustration/File Photo
FILE PHOTO: A view shows a Microsoft logo at Microsof... |
30.07.2024 | The Future of Order Management: AI's Role in Streamlining Business Operations | In the fast-paced world of business, efficiency is king. Companies juggle a myriad of customer orders daily, often through a chaotic mix of emails, PDFs, and voice messages. This jumble creates bottlenecks, slowing down the entire process. ... |
30.07.2024 | European Commission approves Roche’s Vabysmo for treatment of retinal vein occlusion (RVO) | Approval is based on data from two Phase III studies in branch and central retinal vein occlusion (RVO) showing early and sustained vision improvements non-inferior to aflibercept, and robust retinal drying with VabysmoAdditional submitted ... |
30.07.2024 | BioIVT Appoints Dr. Judith Dunn and Dr. Auro Nair to its Board of Directors | WESTBURY, N.Y., July 30, 2024 /PRNewswire/ -- BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced the appointment of Dr. Judith Dunn and Dr. Auro Nair to its Board of Dir... |
29.07.2024 | Mit KI-Mitarbeiter «Adam» Bestellungen schneller bearbeiten |
In Unternehmen, die täglich Kundenbestellungen oder Anfragen in unterschiedlichster Form - von Mails mit der Bestellung im Textfeld oder angehängt als PDF, bis hin zur Bestellaufgabe via Nachricht auf dem Anrufbeantworter – erhalten, ist v... |
29.07.2024 | Roche closes acquisition of LumiraDx’s Point of Care technology to expand access to diagnostic testing in primary care | The acquisition of LumiraDx’s Point of Care technology received all required antitrust and regulatory clearances.LumiraDx’s transformative Point of Care solution will complement Roche’s diagnostics portfolio across Clinical Chemistry, Immun... |
29.07.2024 | Global Icon Malala Yousafzai to Headline APACMed's MedTech Forum in Singapore | SINGAPORE, July 29, 2024 /PRNewswire/ -- APACMed is thrilled to announce that Nobel Laureate and global icon Malala Yousafzai will take centre stage at this year's MedTech Forum, taking place on September 5th and 6th at the Suntec Conventio... |
27.07.2024 | The Future of Diagnostics: Roche's Vision Unveiled at ADLM 2024 | In the bustling heart of Chicago, Roche is setting the stage for the future of laboratory diagnostics. At the 2024 Association for Diagnostics & Laboratory Medicine (ADLM) Clinical Lab Expo, the company is showcasing a suite of innovati... |
27.07.2024 | The Future of Brain Health: Innovations and Leadership in Alzheimer's and Multiple Sclerosis Treatments | In the ever-evolving landscape of biotechnology, two companies are making waves in the treatment of chronic neurological diseases: Immunic, Inc. and Neurophet. Both are leveraging advanced technologies and seasoned leadership to tackle the ... |
26.07.2024 | Advancing Dermatological Research: The American Skin Association's 2024 Grants**
** | ** The American Skin Association (ASA) has taken a bold step forward in the fight against skin diseases. On July 22, 2024, the ASA announced its 2024 research grants, a lifeline for scientists dedicated to understanding and treating skin co... |
26.07.2024 | BioVaxys and Innovent: Pioneering New Frontiers in Immunotherapy and Diabetes Treatment**
** | ** In the ever-evolving landscape of biopharmaceuticals, two companies are making waves: BioVaxys Technology Corp. and Innovent Biologics. Each is tackling significant health challenges with innovative approaches. BioVaxys is focused on imm... |
25.07.2024 | Roche showcases solutions for laboratories of the future at the Association for Diagnostics & Laboratory Medicine 2024 Clinical Lab Expo | Roche will unveil the next generation of core lab and molecular systems, including a total solution for clinical mass spectrometry.
Attendees can experience firsthand how fully integrated systems and data solutions can streamline lab operat... |
25.07.2024 | [Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 5% (CER) in first half of 2024; strong growth in second quarter – full-year earnings outlook raised | Group sales were up by 5%1 at constant exchange rates (CER) (stable in CHF) in the first half, driven by the high demand for both our medicines and diagnostics; excluding COVID-19-related products, sales increased by 8%
Group sales growth a... |
24.07.2024 | Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec | – Senior Executive and Thought Leader in Brain Health with Nearly Three Decades of Global Pharmaceutical Experience –
– Served as Neuroimmunology Franchise Head Responsible for Roche's Blockbuster Launch of Multiple Sclerosis Therapy Ocrevu... |
23.07.2024 | Erfahrene Expertinnen und Experten verstärken Startup-Management |
Das EHT-Spin-off Riverkin begrüsst mit Nitin Kumar and Marco Adriano Magno zwei neue Mitgründer. Nitin Kumar hat einen Doktortitel in Computational Biology und war an einigen erfolgreichen Startup-Exits beteiligt. Mit diesen Erfahrungen kö... |
22.07.2024 | Innovent Announces the Second Phase 3 Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints, and Plans to Submit NDA of Mazdutide to the NMPA | SAN FRANCISCO and SUZHOU, China, July 22, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatmen... |
10.07.2024 | BOLDEN THERAPEUTICS TO PRESENT AT THE 4TH ANNUAL OLIGONUCLEOTIDES FOR CNS SUMMIT | PROVIDENCE, R.I., July 10, 2024 /PRNewswire/ -- Bolden Therapeutics, Inc., a biotechnology company developing first-in-class therapeutics to promote neurogenesis for the potential treatment of CNS illnesses, today announced their invitation... |
09.07.2024 | Roche receives CE Mark for its AI-enabled continuous glucose monitoring solution offering critical predictions to people living with diabetes | The Accu-Chek® SmartGuide CGM solution provides 14 days of accurate1 real-time glucose values for adults living with type 1 and type 2 diabetes on flexible insulin therapy.The built-in AI-trained algorithms will empower users to proactively... |
08.07.2024 | Roche to reintroduce Susvimo in the US for people with neovascular age-related macular degeneration (nAMD) | The FDA has approved updates to Susvimo, which will be available to US retina specialists and patients with nAMD in the coming weeksSusvimo offers the first alternative to regular eye injections that are standard of care for nAMD, which imp... |
07.07.2024 | Hainan Free Trade Port deepens cooperation with Switzerland | HAIKOU, China, July 7, 2024 /PRNewswire/ -- A report from Hainan International Media Center (HIMC):
On July 4, the Hainan Free Trade Port Medical & Health Industry Exchange Meeting was held in Zurich, Switzerland.
From July 4-6, a deleg... |
02.07.2024 | Following a strategic pivot, Release Therapeutics hires a new CEO |
Release Tx is developing a proprietary technology capable of delivering highly potent therapeutic proteins beyond the blood-brain barrier (BBB) for the long-term treatment of CNS disorders. Consisting of an macroencapsulation device, that ... |
28.06.2024 | CHMP recommends EU approval of Roche’s PiaSky for people with PNH, a rare, life-threatening blood condition | If approved, PiaSky will be the first monthly subcutaneous (SC) treatment for paroxysmal nocturnal haemoglobinuria (PNH) in the EU Additionally, with the option to self-administer, PiaSky may provide an alternative to existing intravenous (... |
28.06.2024 | Roche’s Vabysmo gets CHMP recommendation for third indication retinal vein occlusion (RVO) | Positive recommendation is based on two Phase III studies. In addition to robust retinal drying with Vabysmo, these data show early and sustained vision improvements, which are non-inferior to aflibercept If approved, Vabysmo would be the f... |
25.06.2024 | TPG: Significant Strategic Growth Investment In K2 Medical Research | Leading global alternative asset management firm TPG announced a significant strategic growth investment in K2 Medical Research, an integrated clinical trial site platform that specializes in central nervous system (CNS) trials for leading ... |
25.06.2024 | Black and Hispanic Patients Face Higher Liver Cancer ED Visits, Study Finds | What You Should Know:
– A new study by Inovalon, a leader in healthcare data analytics, sheds light on racial and socioeconomic disparities in emergency department (ED) visits for patients with hepatocellular carcinoma (HCC), the most commo... |
24.06.2024 | Roche launches new analytical units for cobas® pro integrated solutions delivering greater efficiency and capacity to laboratories | The cobas® c 703 and cobas® ISE neo analytical units, deliver higher testing capacity and increased automation helping to improve laboratory workflows and advance patient care.The new cobas c 703 analytical unit offers industry-leading high... |
21.06.2024 | Envision Energy's Path to Net Zero: A Green Revolution Unveiled | Envision Energy, a global leader in green technology, has unveiled its 2024 Net Zero Action Report at Intersolar in Munich, showcasing its remarkable achievements in global decarbonization. This report marks the company's second consecutive... |
21.06.2024 | Envision Energy Releases 2024 Net Zero Action Report Highlighting Global Decarbonization Achievements | MUNICH, June 21, 2024 /PRNewswire/ -- Envision Energy, a global leader in green technology, has unveiled its 2024 Net Zero Action Report at Intersolar in Munich. This report highlights the company's ongoing decarbonization achievements, mar... |
20.06.2024 | Envision Energy Releases 2024 Net Zero Action Report Highlighting Global Decarbonization Achievements | MUNICH, June 20, 2024 /PRNewswire/ -- Envision Energy, a global leader in green technology, has unveiled its 2024 Net Zero Action Report in Intersolar, declaring its second consecutive year of carbon-neutral operations on a global scale. Th... |
20.06.2024 | Roche launches new highly-sensitive test to more easily diagnose patients who may have B-cell lymphoma | The VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay is the first clinically approved in-situ hybridisation (ISH) test with the sensitivity to assess the full spectrum of B-cell lymphoma subtypes.1,2The test helps differentiate a... |
18.06.2024 | The Battle Against Mutant Flu and Deadly Mpox | The CDC tracks drug-resistant "dual mutant" flu strains in the US, while South Africa faces its first mpox fatality and scrambles for a vaccine.
In the ongoing war against infectious diseases, the Centers for Disease Control and P... |
18.06.2024 | Выдающийся врач-онколог Павел Борисович Попов: от детских экспериментов до мировой славы | - |
17.06.2024 | Companion Diagnostics Market Size to Reach $13.74 Billion by 2030: Latest Report by Vantage Market Research | According to a market research study published by Vantage Market Research, the demand analysis of Global Companion Diagnostics Market size revenue was valued at approximately $5.59 Bn in 2022 and is expected to reach around $13.74 Bn by 203... |
15.06.2024 | Roche’s Phase III STARGLO study demonstrates Columvi significantly extends survival in people with relapsed or refractory diffuse large B-cell lymphoma | The study met its primary endpoint of overall survival with a 41% reduction in the risk of death in people with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) treated with Columvi plus chemotherapy1
This Columvi combinat... |
12.06.2024 | Drug-resistant "dual mutant" flu strains now being tracked in U.S., CDC says | At least two human cases of the new so-called "dual mutant" strains of H1N1 influenza have been detected in U.S. patients, the Centers for Disease Control and Prevention said Wednesday, with genetic changes that could cut the effe... |
10.06.2024 | Blood Test for Alzheimer’s on the Horizon: ALZpath Licenses pTau217 Antibody to Roche | What You Should Know:
– ALZpath, a leader in Alzheimer’s disease diagnostics, announced a licensing agreement with Roche for their innovative pTau217 antibody. This paves the way for a blood test to diagnose Alzheimer’s disease using Roche’... |
10.06.2024 | European Commission approves Roche’s Alecensa as the first and only targeted adjuvant treatment for people with ALK-positive early-stage lung cancer | European Commission approves Roche’s Alecensa as the first and only targeted adjuvant treatment for people with ALK-positive early-stage lung cancer Alecensa reduced the risk of disease recurrence or death by an unprecedented 76% in people ... |
10.06.2024 | Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization | The test uses highly sensitive PCR technology, requiring only a single nasal-swab sample to provide rapid, accurate qualitative detection and differentiation among four of the most prevalent respiratory viruses for which differential diagno... |
07.06.2024 | «Мы должны иметь возможность в любой момент развернуть производство востребованных лекарств» | - |
05.06.2024 | Chronus Acquires Imperative | Chronus, a Seattle, WA-based provider of an employee-driven development platform offering mentorship and ERG management, acquired Imperative, a Seattle, WA-based employee engagement platform.
The amount of the del was not disclosed.
The add... |
03.06.2024 | Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatme... | SAN FRANCISCO and SUZHOU, China, June 3, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for t... |
03.06.2024 | Bring Out Your Best: SAP Business AI | What is The News About?
“Bring Out Your Best: SAP Business AI” was the theme of SAP’s annual flagship event, “SAP NOW Hong Kong2024“. At this event, more than 400 thought leaders from various fields came together to discuss the potential of... |
30.05.2024 | US, UK in focus as pharma companies eye $31 billion exports in FY25 | - |
29.05.2024 | «Фармпроизводителям искусственно ограничивают доходность» | - |
27.05.2024 | Drugmakers to see FY25 revenue boost in key US market: India Ratings | - |
22.05.2024 | Швейцарская мирная преференция | - |
22.05.2024 | Analysis:Europe stock pickers go old-school to ride the next wave in AI | LONDON : European stock pickers are turning to more established sectors like utilities, professional data providers and even copper miners to tap into the next wave of the AI boom, a year after AI chipmaker Nvidia's emergence as a driving f... |
21.05.2024 | Innovent Announces the New Drug Application of IBI311 (IGF-1R antibody) has been Accepted by the NMPA of China for Thyroid Eye Disease | SAN FRANCISCO and SUZHOU, China, May 21, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for t... |
21.05.2024 | Department of Health - Abu Dhabi Partners with Roche Pharmaceuticals Middle East to Elevate Research, Clinical Trials, and Real-World Data | ABU DHABI, UAE, May 21, 2024 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding (MoU) with Roche Pharmaceuticals Middle East during Abu Dha... |
20.05.2024 | Innovent Announces Oral Presentations at ESMO Plenary and ESMO GI Congress on Clinical Data of IBI363 (PD-1/IL-2) and IBI343 (CLDN18.2 ADC) | SAN FRANCISCO and SUZHOU, China, May 19, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for t... |
20.05.2024 | Calibre One Announces its First International Practice Group | Calibre One, a leading global executive search boutique specializing in building leadership teams for innovators, entrepreneurs and companies undergoing transformations, is thrilled to announce its newest practice group. Recognizing the gro... |
14.05.2024 | Germany Records Big Rise in Foreign Direct Investment in 2023 | The volume of international business expansions to and in Europe's largest economy increased by over 37 percent last year.
BERLIN, May 14, 2024 /PRNewswire/ -- Germany attracted 34.8 billion euros worth of international business projects in... |
14.05.2024 | Germany Records Big Rise in Foreign Direct Investment in 2023 | The volume of international business expansions to and in Europe's largest economy increased by over 37 percent last year.
BERLIN, May 14, 2024 /PRNewswire/ -- Germany attracted 34.8 billion euros worth of international business projects in... |
10.05.2024 | Nations struggle to draft pandemic treaty to avoid mistakes made in Covid | - |
09.05.2024 | Head-to-head Superiority to High-dose Dulaglutide: Innovent's First Phase 3 Clinical Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints | SAN FRANCISCO and SUZHOU, China, May 9, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment ... |
09.05.2024 | Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer | US$5 million PanCAN grant provides important support for the fifth cohort of the GOBLET study
Study of modified FOLFIRINOX/pelareorep/atezolizumab (Tecentriq®) combination expands existing pancreatic cancer program
First patient expected to... |
03.05.2024 | Indicium: A Rising Star in Data and AI Consultancy | Indicium, a Brazilian data and artificial intelligence consultancy startup, recently secured a whopping $40 million in funding to fuel its expansion in the U.S. market. Founded in 2017, Indicium has quickly made a name for itself by helping... |
02.05.2024 | Brazilian data and AI consultancy Indicium raises $40M for US expansion
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to provide f... | Brazilian data and artificial intelligence consultancy startup Indicium today announced that it had raised $40 million in new funding to expand its operations in the U.S.
Founded in 2017, Indicium helps enterprises become “data-driven” usin... |
27.04.2024 | India becoming attractive for clinical trials, says pharma industry leaders | - |
24.04.2024 | Pharma exports rise around 10% to $27.9 billion, US biggest importer | - |
24.04.2024 | Govt expands committee for drugs, medical devices pricing reforms | - |
23.04.2024 | The future of healthcare on display: Day 1 of Medlab West Africa wraps up | The first day of the highly anticipated Medlab West Africa Exhibition and Conference has drawn to a close, leaving attendees and exhibitors alike buzzing with excitement. The venue was a hive of activity, showcasing the latest advancements ... |